Cheng Linxiang, Zheng Qiangqiang, Qiu Kaijie, Elmer Ker Dai Fei, Chen Xiao, Yin Zi
Department of Orthopedic Surgery of Sir Run Run Shaw Hospital, and Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China.
Dr. Li Dak Sum & Yip Yio Chin Center for Stem Cells and Regenerative Medicine, Zhejiang University School of Medicine, Hangzhou, China.
J Orthop Translat. 2024 Oct 3;49:49-61. doi: 10.1016/j.jot.2024.09.003. eCollection 2024 Nov.
Tendinopathy is a prevalent aging-related disorder characterized by pain, swelling, and impaired function, often resulting from micro-scarring and degeneration caused by overuse or trauma. Current interventions for tendinopathy have limited efficacy, highlighting the need for innovative therapies. Mitochondria play an underappreciated and yet crucial role in tenocytes function, including energy production, redox homeostasis, autophagy, and calcium regulation. Abnormalities in mitochondrial function may lead to cellular senescence. Within this context, this review provides an overview of the physiological functions of mitochondria in tendons and presents current insights into mitochondrial dysfunction in tendinopathy. It also proposes potential therapeutic strategies that focus on targeting mitochondrial health in tenocytes. These strategies include: (1) utilizing reactive oxygen species (ROS) scavengers to mitigate the detrimental effects of aberrant mitochondria, (2) employing mitochondria-protecting agents to reduce the production of dysfunctional mitochondria, and (3) supplementing with exogenous normal mitochondria. In conclusion, mitochondria-targeted therapies hold great promise for restoring mitochondrial function and improving outcomes in patients with tendinopathy. : Tendinopathy is challenging to treat effectively due to its poorly understood pathogenesis. This review thoroughly analyzes the role of mitochondria in tenocytes and proposes potential strategies for the mitochondrial treatment of tendinopathy. These findings establish a theoretical basis for future research and the clinical translation of mitochondrial therapy for tendinopathy.
肌腱病是一种常见的与衰老相关的疾病,其特征为疼痛、肿胀和功能受损,通常由过度使用或创伤引起的微疤痕形成和退变所致。目前针对肌腱病的干预措施疗效有限,这凸显了创新疗法的必要性。线粒体在肌腱细胞功能中发挥着未得到充分重视但至关重要的作用,包括能量产生、氧化还原稳态、自噬和钙调节。线粒体功能异常可能导致细胞衰老。在此背景下,本综述概述了线粒体在肌腱中的生理功能,并介绍了目前对肌腱病中线粒体功能障碍的见解。它还提出了以肌腱细胞线粒体健康为靶点的潜在治疗策略。这些策略包括:(1)利用活性氧(ROS)清除剂减轻异常线粒体的有害影响;(2)使用线粒体保护剂减少功能失调线粒体的产生;(3)补充外源性正常线粒体。总之,针对线粒体的疗法在恢复肌腱病患者的线粒体功能和改善治疗效果方面具有巨大潜力。由于肌腱病的发病机制尚不清楚,因此有效治疗具有挑战性。本综述深入分析了线粒体在肌腱细胞中的作用,并提出了线粒体治疗肌腱病的潜在策略。这些发现为未来肌腱病线粒体治疗的研究和临床转化奠定了理论基础。